To play content please upgrade your flash player to the latest version.
Responding to guidance issued today by Medicines and Healthcare products Regulatory Agency (MHRA), that cough and cold treatments should not be used for infants and children under 2 years of age, the Royal Pharmaceutical Society of Great Britain (RPSGB) has called on pharmacists to review how such products are stored and sold.
Audio 
Sorry. There is no audio currently available for this story.
